Circulating tumor DNA response adapted treatment de-escalation in metastatic urothelial carcinoma (CT-READ). The GAIN trial: Gemcitabine alternating with intravesical BCG randomized against BCG alone ...
First CTA authorization marks nChroma’s transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...
BOSTON, December 16, 2025--(BUSINESS WIRE)--nChroma Bio ("nChroma"), a genetic medicines company advancing in vivo delivery of innovative cargoes to overcome the limitations of existing therapies, ...
Professor James Wolffsohn and Dr. Amy Sheppard from Aston University School of Optometry are part of a new study which will explore how screen time affects babies and their families during the first ...
As the new school year approaches, Google announced on Wednesday that it’s launching a new tool called Guided Learning within Gemini. The tool sort of functions like an AI tutor, as it’s designed to ...
OpenAI has launched a new “study mode” for ChatGPT that’s designed to help students better understand complex topics—but instead of dishing out direct answers, study mode employs the Socratic method ...
OpenAI has announced a new study mode for ChatGPT that helps students work through problems step by step — instead of just providing an answer. "When students engage with study mode, they're met with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results